{
  "DRAMP ID": "DRAMP00017",
  "Sequence": "VTSWSLCTPGCTSPGGGSNCSFCC",
  "scores": {
    "mic": 6.0,
    "hemolysis": 9.0,
    "cytotoxicity": 2.0,
    "boman_score": 7.0,
    "protease": 10.0,
    "ph_thermal": 5.0,
    "half_life": 10,
    "length": 10.0,
    "rare_aa": 10.0,
    "disulfide": 8.0
  },
  "weighted_scores": {
    "efficacy": 2.16,
    "toxicity": 1.5750000000000002,
    "stability": 1.6,
    "synthesis": 1.38
  },
  "total": 6.715,
  "APD3": {
    "sequence": "VTSWSLCTPGCTSPGGGSNCSFCC",
    "length": 24,
    "hydrophobic_ratio": 37.0,
    "net_charge": 0,
    "molecular_weight": null,
    "gravy_value": null,
    "disulfide_bonds": 2,
    "detailed_info_fetched": true,
    "from_local_apd3": true,
    "apd_id": "AP01617",
    "detail_info": {
      "name_class": "Microbisporicin A1 (natural AMPs; type AI lantibiotic 107891, NAI-107, class 1 bacteriocin; Gram-positive bacteria, prokaryotes; XXT5, XXW2,UCSS1b;XXH,XXK;BBW; Variants: microbisporicin A2; NAI-108)",
      "source": "Microbispora sp., strain 107891; or Microbispora sp., PTA-5024, Microbispora ATCC-PTA-5024",
      "sequence": "VTSWSLCTPGCTSPGGGSNCSFCC",
      "activity": "Anti-Gram+, Anti-MRSA",
      "crucial_residues": "",
      "additional_info": "Discovery: Identified by genome scanning and isolated from an M. corallina cosmid library. NAI-107 production started at 90 h (A stage), reached a maximum at 140 h (D stage) and decreased thereafter(Gallo G et al., 2016).Chemical modification:  Microbisporicin A1 has five thioether rings: S3-C7, T8-C11, S13-C20, S18-C23, and S21-C24. Also, residues T2 and S5 are dehydrated. Unprecedently, Trp4 is chlorinated (5-Cl-) and Pro14 is hydroxylated (3,4-dihydroxylation).Variant: Interestingly, microbisporicin A2 shares the same amino acid sequence with A1 with the only difference being that Pro14 is only monohydroxylated at position 4.SAR: NAI-108 is a bromonated variant of NAI-107. It is obtained by inclusion of KBr in the production medium of either the Actinoallomurus or the Microbispora producer. This is the first brominated lantibiotic, which makes it more potent due to increase in hydrophobicity (Cruz JC et al., 2015).MOA:bacteria: Microbisporicins A1 and A2 displayed similar antibacterial activity by selectively blocking peptidoglycan biosynthesis, leading to cytoplasmic accumulation of the UDP-linked precursor.Structure:  the NMR structure is a non alpha beta structure (Vasile et al., 2012).Animal model:fruit fly:  The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 with an efficacy equivalent to that of vancomycin  (Thomsen et al., 2016).Updated 5/28/2014; 9/2016; 5/2023; 12/2024.",
      "reference": "Chem Biol. 2008 Jan;15(1):22-31.PubMed",
      "boman_index": 0.28,
      "length": 24,
      "net_charge": 0,
      "hydrophobic_ratio": 37.0,
      "disulfide_bonds": 2,
      "is_two_chain": false,
      "has_synergy": false
    },
    "boman_index": 0.28
  },
  "target_organisms": {
    "Human pathogens": [
      {
        "name": "Propionibacterium limphophylum ATCC27250",
        "activity": "MIC: 0.015 μg/ml"
      },
      {
        "name": "Propionibacterium granulosum ATCC25564",
        "activity": "MIC: 0.03 μg/ml"
      },
      {
        "name": "L76 Moraxella catarrhalis ATCC8176",
        "activity": "MIC: 0.25 μg/ml"
      },
      {
        "name": "L997 Neisseria gonorrhoeae",
        "activity": "MIC: 0.25 μg/ml"
      },
      {
        "name": "L560 Enterococcus faecalis Van A",
        "activity": "MIC: 0.5 μg/ml"
      },
      {
        "name": "L1329 Propionibacterium acnes",
        "activity": "MIC: 0.5 μg/ml"
      },
      {
        "name": "L1613 Neisseria meningitidis ATCC13090V",
        "activity": "MIC: 0.5 μg/ml"
      },
      {
        "name": "L559 Enterococcus faecalis",
        "activity": "MIC: 1 μg/ml"
      },
      {
        "name": "LA533 Enterococcus faecalis Van A",
        "activity": "MIC: 1 μg/ml"
      },
      {
        "name": "L569 Enterococcus faecium Van A",
        "activity": "MIC: 1 μg/ml"
      },
      {
        "name": "L884 Lactobacillus garviae",
        "activity": "MIC: 1 μg/ml"
      },
      {
        "name": "L3798 S. aureus VISA",
        "activity": "MIC: 2 μg/ml"
      },
      {
        "name": "L568 Enterococcus faecium",
        "activity": "MIC: 2 μg/ml"
      },
      {
        "name": "LB518 E. faecium Van A",
        "activity": "MIC: 2 μg/ml"
      },
      {
        "name": "L148 Lactobacillus delbrueckii ATCC04797",
        "activity": "MIC: 4 μg/ml"
      },
      {
        "name": "L1729 Staphylococcus haemolyticus met-r",
        "activity": "MIC: 8 μg/ml"
      },
      {
        "name": "L970 Haemophilus influenzae ATCC19418",
        "activity": "MIC: 32 μg/ml"
      },
      {
        "name": "L100 Staphylococcus aureus ATCC6538P",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L819 Staphylococcus aureus Smith ATCC19636",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L1400 S. aureus MRSA",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L613 S. aureus MRSA",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L3798 Staphylococcus epidermidis ATCC12228",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L49 Streptococcus pyogenes",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L44 Streptococcus pneumoniae",
        "activity": "(MIC≤0.13 μg/ml)"
      },
      {
        "name": "L3607 Clostridium perfringens ATCC13124",
        "activity": "(MIC≤0.125 μg/ml)"
      },
      {
        "name": "L4018 Clostridium difficile",
        "activity": "(MIC≤0.125 μg/ml)"
      },
      {
        "name": "L4043 Clostridium butyricum",
        "activity": "(MIC≤0.125 μg/ml)"
      }
    ]
  }
}